At the U.S. Food and Drug Administration's (FDA) request, Vinay Prasad is returning to the role of director of the Center for ...

Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to ...

Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...

The Food and Drug Administration restored a top vaccine regulator to his position at the agency just weeks after firing him.

Novavax ( ($NVAX) ) has risen by 24.00%. Read on to learn why. Novavax has experienced a notable 24.00% increase in its stock price over the past ...

Latest move to cut funding for vaccines is not down to US health secretary. It is part of Trump’s wider war on science.

BTIG analyst Thomas Shrader maintained a Hold rating on Inmune Bio ( INMB – Research Report) yesterday. The company’s shares closed yesterday at $2.31. Take advantage of TipRanks Premium at 50% off!